MeiraGTx Holdings plc (MGTX) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
39/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 8 wins, 4 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinMGTX / S&P 56.00% / 15.20% |
WinMGTX / S&P 948.35% / 15.00% |
LoseMGTX / S&P -134.80% / 50.40% |
| 2026-Q12/3 |
WinMGTX / S&P 8.93% / -4.33% |
WinMGTX / S&P 131.13% / 11.30% |
LoseMGTX / S&P -36.21% / 27.70% |
| 2025-Q41/3 |
LoseMGTX / S&P -3.40% / 2.65% |
WinMGTX / S&P 144.57% / 9.00% |
LoseMGTX / S&P -33.33% / 13.40% |
| 2025-Q33/3 |
WinMGTX / S&P 26.23% / 8.12% |
WinMGTX / S&P 96.83% / 4.61% |
WinMGTX / S&P 74.38% / 13.45% |
| 2025-Q22/3 |
LoseMGTX / S&P -3.83% / 10.94% |
WinMGTX / S&P 366.84% / 4.83% |
WinMGTX / S&P 45.71% / 10.63% |
| 2025-Q13/3 |
WinMGTX / S&P 11.33% / -4.27% |
WinMGTX / S&P 203.23% / 4.98% |
WinMGTX / S&P 98.29% / 10.57% |
| 2024-Q43/3 |
WinMGTX / S&P 46.04% / 2.41% |
WinMGTX / S&P 137.42% / 5.25% |
WinMGTX / S&P 44.90% / 6.15% |
| 2024-Q31/3 |
LoseMGTX / S&P -0.95% / 5.89% |
WinMGTX / S&P 108.24% / 5.89% |
LoseMGTX / S&P -51.01% / 6.11% |
| 2024-Q21/3 |
LoseMGTX / S&P -30.64% / 4.28% |
WinMGTX / S&P 26.87% / 5.38% |
LoseMGTX / S&P -45.31% / 5.12% |
| 2024-Q10/3 |
LoseMGTX / S&P -13.53% / 10.56% |
LoseMGTX / S&P -16.45% / 5.71% |
LoseMGTX / S&P -58.06% / 5.59% |
| 2023-Q41/3 |
WinMGTX / S&P 42.97% / 11.69% |
LoseMGTX / S&P -11.95% / 6.81% |
LoseMGTX / S&P -48.78% / 7.78% |
| 2023-Q31/3 |
LoseMGTX / S&P -26.93% / -3.27% |
LoseMGTX / S&P -84.17% / 7.52% |
WinMGTX / S&P -1.59% / -5.03% |
| 2023-Q22/3 |
WinMGTX / S&P 29.98% / 8.74% |
LoseMGTX / S&P -85.58% / 9.50% |
WinMGTX / S&P 12.78% / -8.57% |
| 2023-Q11/3 |
LoseMGTX / S&P -20.71% / 7.50% |
LoseMGTX / S&P -64.84% / 10.77% |
WinMGTX / S&P 41.62% / -15.69% |
| 2022-Q41/3 |
LoseMGTX / S&P -22.47% / 7.56% |
LoseMGTX / S&P -57.77% / 11.88% |
WinMGTX / S&P 58.56% / -17.99% |
| 2022-Q33/3 |
WinMGTX / S&P 11.10% / -4.88% |
WinMGTX / S&P 106.64% / 13.47% |
WinMGTX / S&P 36.41% / -1.41% |
| 2022-Q22/3 |
LoseMGTX / S&P -45.34% / -16.10% |
WinMGTX / S&P 138.73% / 13.71% |
WinMGTX / S&P 59.86% / 11.04% |
| 2022-Q11/3 |
LoseMGTX / S&P -41.66% / -4.60% |
WinMGTX / S&P 142.90% / 15.97% |
LoseMGTX / S&P MGTX unavailable / 42.23% |
| 2021-Q42/3 |
WinMGTX / S&P 80.12% / 11.03% |
WinMGTX / S&P 142.24% / 15.00% |
LoseMGTX / S&P MGTX unavailable / 96.40% |
| 2021-Q30/3 |
LoseMGTX / S&P -14.97% / 0.58% |
LoseMGTX / S&P 9.23% / 10.77% |
LoseMGTX / S&P MGTX unavailable / 69.42% |
| 2021-Q21/3 |
LoseMGTX / S&P 7.42% / 8.55% |
WinMGTX / S&P 8.03% / 6.58% |
LoseMGTX / S&P MGTX unavailable / 51.81% |
| 2021-Q10/3 |
LoseMGTX / S&P -4.69% / 6.17% |
LoseMGTX / S&P -4.59% / -1.06% |
LoseMGTX / S&P MGTX unavailable / 7.39% |
| 2020-Q42/3 |
WinMGTX / S&P 14.35% / 12.15% |
WinMGTX / S&P 17.09% / -3.72% |
LoseMGTX / S&P MGTX unavailable / -33.42% |
| 2020-Q30/3 |
LoseMGTX / S&P 5.75% / 8.93% |
LoseMGTX / S&P MGTX unavailable / -2.04% |
LoseMGTX / S&P MGTX unavailable / -27.10% |
| 2020-Q20/3 |
LoseMGTX / S&P -6.85% / 20.54% |
LoseMGTX / S&P MGTX unavailable / -0.46% |
LoseMGTX / S&P MGTX unavailable / -27.11% |
| 2020-Q10/3 |
LoseMGTX / S&P -32.87% / -19.60% |
LoseMGTX / S&P MGTX unavailable / 3.47% |
LoseMGTX / S&P MGTX unavailable / -14.75% |
| 2019-Q41/3 |
WinMGTX / S&P 25.52% / 9.07% |
LoseMGTX / S&P MGTX unavailable / 5.36% |
LoseMGTX / S&P MGTX unavailable / 2.99% |
| 2019-Q30/3 |
LoseMGTX / S&P -40.66% / 1.70% |
LoseMGTX / S&P MGTX unavailable / 5.02% |
LoseMGTX / S&P MGTX unavailable / 0.21% |
| 2019-Q21/3 |
WinMGTX / S&P 56.01% / 4.30% |
LoseMGTX / S&P MGTX unavailable / 6.64% |
LoseMGTX / S&P MGTX unavailable / 8.65% |
| 2019-Q11/3 |
WinMGTX / S&P 78.73% / 13.65% |
LoseMGTX / S&P MGTX unavailable / 8.12% |
LoseMGTX / S&P MGTX unavailable / 14.29% |
| 2018-Q40/3 |
LoseMGTX / S&P -29.12% / -13.52% |
LoseMGTX / S&P MGTX unavailable / 9.05% |
LoseMGTX / S&P MGTX unavailable / 18.23% |
| 2018-Q31/3 |
WinMGTX / S&P 18.67% / 7.71% |
LoseMGTX / S&P MGTX unavailable / 10.21% |
LoseMGTX / S&P MGTX unavailable / 19.06% |
| 2018-Q20/3 |
LoseMGTX / S&P MGTX unavailable / 3.43% |
LoseMGTX / S&P MGTX unavailable / 9.03% |
LoseMGTX / S&P MGTX unavailable / 14.46% |
| 2018-Q10/3 |
LoseMGTX / S&P MGTX unavailable / -0.76% |
LoseMGTX / S&P MGTX unavailable / 7.68% |
LoseMGTX / S&P MGTX unavailable / 12.46% |
| 2017-Q40/3 |
LoseMGTX / S&P MGTX unavailable / 6.64% |
LoseMGTX / S&P MGTX unavailable / 7.03% |
LoseMGTX / S&P MGTX unavailable / 13.82% |
| 2017-Q30/3 |
LoseMGTX / S&P MGTX unavailable / 4.48% |
LoseMGTX / S&P MGTX unavailable / 5.68% |
LoseMGTX / S&P MGTX unavailable / 17.57% |
| 2017-Q20/3 |
LoseMGTX / S&P MGTX unavailable / 3.09% |
LoseMGTX / S&P MGTX unavailable / 4.83% |
LoseMGTX / S&P MGTX unavailable / 17.74% |
| 2017-Q10/3 |
LoseMGTX / S&P MGTX unavailable / 6.07% |
LoseMGTX / S&P MGTX unavailable / 3.67% |
LoseMGTX / S&P MGTX unavailable / 13.32% |
| 2016-Q40/3 |
LoseMGTX / S&P MGTX unavailable / 3.82% |
LoseMGTX / S&P MGTX unavailable / 2.09% |
LoseMGTX / S&P MGTX unavailable / 7.05% |
| 2016-Q30/3 |
LoseMGTX / S&P MGTX unavailable / 3.85% |
LoseMGTX / S&P MGTX unavailable / 0.20% |
LoseMGTX / S&P MGTX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | MGTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 93.70% | 20.78% |
| Annualized return | 93.70% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | MGTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 12.04% | 83.14% |
| Annualized return | 2.30% | 12.86% |
10Y · 2018-06-08 to 2026-08-27
| Metric | MGTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -5.73% | 319.30% |
| Annualized return | -0.59% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |